Climb’s Innovation Continues at Instem

Following Instem’s recent acquisition of RockStep Solutions and their non-GLP study management solution Climb™, momentum continues to build around this innovative in vivo study management solution.
Morningstar

Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation

AI-powered insights from the Veradigm Network reveal real-world GLP-1 outcomes hidden in EHR data Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced ...
Morningstar

Chalk River Laboratories Becomes First GLP-Certified Laboratory in Canada to Offer Pre-Clinical Radiopharmaceutical Studies

CHALK RIVER, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that the Chalk River ...
Medscape

Reassuring Data on GLP-1 RAs and Pancreatic Cancer Risk

PHILADELPHIA — New research provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) do not increase the risk for pancreatic cancer. Instead, the large electronic health ...